What is AF710B?
Leave a message
Why is there an increasing trend of innovative drug research targeting neurological diseases? Why is AF710B being favored by so many laboratories and pharmaceutical companies as a potential nootropic ingredient? Why are there so many studies on nootropic APIs now, in 2016? What is AF710B? The following is a description of the compound AF710B.
What is AF710B?
AF710B is a selective allosteric agonist of:
M1 muscarinic acetylcholine receptor (M1 mAChR)
Sigma-1 receptor (σ1R)
This dual-target profile distinguishes it from traditional single-pathway Alzheimer's drugs.
According to published research, AF710B works at very low concentrations and enhances endogenous cholinergic signaling rather than overstimulating receptors-resulting in improved safety and efficacy profiles.
Difference: Unlike traditional cholinergic drugs, AF710B is more significant in drug development and raw material procurement because of its different mechanism of action; AF710B has a multi-target mechanism of action.
What are the functions of AF710B?
1. Can AF710B be a potential ingredient for improving cognitive function? This is still under investigation, but it may be beneficial for improving learning and memory.
2. Preclinical studies have shown that AF710B has a potential effect on reducing Aβ40 and Aβ42 levels, which may alleviate Alzheimer's disease.
3. AF710B has been shown to salvage synaptic loss in neuronal models, indicating its long-term benefits to brain function.
What are the application areas of AF710B?
1. Currently, AF710B is mainly used as a chemical research raw material in scientific research and pharmaceutical intermediates.
Application areas, besides cognitive function research, also include:
Alzheimer's disease drug development
Neurodegenerative disease research
CNS drug discovery pipelines
FAQ
Q1: As a novel product, has AF710B received commercial approval?
No, AF710B is not currently approved for clinical or other applications and is in the research and preclinical/early development stages.
Q2: How does AF710B differ from other M1 receptor agonists?
AF710B is an allosteric modulator, which may offer better safety.
Q3: Can AF710B currently be used as a supplement?
AF710B is currently only available for pharmaceutical companies and laboratory research.
Q4: What are the main advantages of AF710B for pharmaceutical companies?
Its dual-target mechanism and durable efficacy may make it a potential compound for central nervous system drugs in the future.
Q5: Is AF710B a pharmaceutical raw material?
It is a pharmaceutical raw material used in experiments.
Q6: Are you a manufacturer of AF710B?
Yes, Jinan Jianfeng Chemical supplies high-purity AF710B powder to major pharmaceutical companies.
Q7: Do you provide small quantities of AF710B powder samples?
Of course, as an AF710B supplier, we are happy to provide samples and have COA and other documentation.
Q8: Besides AF710B, do you have any other raw materials?
AF710B is one of the products of Jinan Jianfeng Chemical. The others include TAK-653 and various pharmaceutical raw materials and pharmaceutical intermediates.
If you would like to learn more about "What Are The New Nootropic Raw Materials In 2026?", you can view it via the link.
Disclaimer:
The information on this website is for communication and learning purposes only and is not medical advice. It should not be used for diagnosing or treating any illness.
